32 results
8-K
PCSA
Processa Pharmaceuticals Inc
17 Mar 22
Regulation FD Disclosure
8:30am
with analysts and investors at the Oppenheimer 32nd Annual Healthcare Conference. During these virtual meetings, Processa’s presentation will be uploaded
424B4
gtn wmps3390g
5 Oct 20
Prospectus supplement with pricing info
4:16pm
8-K
EX-99.1
nl8t0kbs
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.1
58cz3 z5hp5tr8p
5 Mar 20
Processa Pharmaceuticals Announces Formation of Its Medical and Scientific Advisory Board
9:30am
DEF 14A
ribxe i4yeisja6bthp
26 Apr 19
Definitive proxy
5:02pm